Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis

Simona Di Giambenedetto, Massimiliano Fabbiani, Manuela Colafigli, M Zaccarelli, C Pinnetti, V Borghi, A Giannetti, G Sterrantino, P Lorenzini, A Latini, L Loiacono, A Ammassari, G D'Ettorre, M Plazzi, A. Antinori

Research output: Contribution to journalConference articlepeer-review

Abstract

To assess the role of drugs used in dual therapy (DT), as cART simplification, over the risk of treatment failure.
Original languageEnglish
Pages (from-to)19802-19802
Number of pages1
JournalJournal of the International AIDS Society
Volume17
Publication statusPublished - 2014
EventHIV Drug Therapy Glasgow Congress 2014 - Glasgow
Duration: 2 Nov 20146 Nov 2014

Keywords

  • HIV
  • therapy

Fingerprint Dive into the research topics of 'Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis'. Together they form a unique fingerprint.

Cite this